Gouty Arthritis
Gouty Arthritis
Gouty Arthritis
Its incidence increases with age and is three times more common in men. In a
study done by Singh (2008), it was found out that new-onset gouty arthritis is
common in the elderly population. This seems to be related to increasing lifespan,
and thus the age-related diseases such as hypertension and effects of associated
treatment as with diuretics.
1. Asymptomatic hyperuricemia
2. Acute gouty arthritis
3. Intercritical gout
4. Chronic tophaceous gout
Intercritical Gout
This is the period between two attacks of gout. Approximately 60% of patients have
a second attack within the first year, and 78% have a second attack within 2 years.
Only 7% of patients do not have a recurrence within a 10-year period, (Singh, 2008).
Risk Factors
Predisposing Factor
Age- Higher incidences of gouty arthritis are reported among elderly clients
specifically 60 years and above. According to healthtalk.org, gouty arthritis
increases with age and frequent attacks happen more often this is because
the kidneys which are responsible for the excretion of this waste material in
the body had a decreased function due to aging process.
Gender- Men tend to develop gouty arthritis earlier than women because men
considered to have high levels of uric acids in their bodies. On the other hand,
women in their postmenopausal years begin to have the same levels of uric
acid level as of those in men since there is already a decline in their hormone
estrogen. Based on the study of McCLory and Said (2009), serum uric acid
levels is regulated by estrogen, a hormone that is predominant among
women, since it enhances renal uric acid excretion.
Race: African-American are at a higher risk of developing gouty arthritis.
According to Singh(2014), African-american had this genetic marker that is
associated with hyperuricemia that places them at increased risk of having
gouty arthritis.
Predisposing Factor
Diet: High in purine diet can increase the risk among older people to develop
gouty arthritis. These food include internal organs of animals, beans , meat,
poultry and etc. because this kind of food are rich in purine, which are
substances converted into uric acid in our body.
Treatment
Probenecid (Benemid)
o This medication helps the body eliminate excess uric acid through the
kidneys and into the urine.
o Individuals should drink at least 2 liters of fluid a day while taking this
medication (to help prevent uric acid kidney stones from forming).
o Advise a doctor if one has kidney problems or a history of kidney
stones or if taking aspirin. One may need to take allopurinol (see
below) instead.
o There are a number of drug interactions with probenecid, so advise a
doctor of other medications. If prescribed a new medication, let a
doctor know that you are taking probenecid.
Allopurinol
o This medication decreases the formation of uric acid by the body and is
a very reliable way to lower the blood uric acid level. Allopurinol is
currently the gold standard of maintenance therapy.
o Advise your doctor if you have kidney problems. Allopurinol can be still
used, but the dose may need to be adjusted.
o Common side effects include stomach pain, headache, diarrhea,
and rash.
o Discontinue allopurinol if you develop a rash or a fever, and call your
doctor.
o A very rare risk of allopurinol hypersensitivity exists. This problem can
cause a severe skin rash, fever, kidney failure, liver failure, bone
marrow failure, and can be fatal.
o Advise your doctor if you are taking azathioprine (Azasan, Imuran), 6-
mercaptopurine, or cyclophosphamide (Cytoxan, Cytoxan
Lyophilized, Neosar); dose adjustments of allopurinol may be needed.
o Ampicillin (Principen) is more likely to cause a rash if you are taking
allopurinol.
Febuxostat (Uloric)
o Febuxostat is first new medication developed specifically for the control
of gout in over 40 years.
o Febuxostat decreases the formation of uric acid by the body and is a
very reliable way to lower the blood uric acid level.
o Febuxostat can be used in patients with mild to moderate kidney
impairment.
o Febuxostat should not be taken with 6-mercaptopurine (6-MP), or
azathioprine.
Pegloticase (Krystexxa)
o Pegloticase is a PEGylated uric acid-specific enzyme given
intravenously that is indicated for the treatment of chronic gout in adult
patients refractory to conventional therapies described above.
o Pegloticase should be avoided if you have G6PD enzyme deficiency.
o Serious allergic reactions can occur with pegloticase, including life-
threatening anaphylaxis.
Desired Outcome:
Treat the acute attack, prevent future flare ups/attacks, lower excess stores of urate.
Rationale: Patients in an acute attack will experience pain and require appropriate
pain control and interventions.
Rationale: Patients may have an impaired ability to mobilize due to inflammation and
pain; assist for safe ambulation and transfer especially in elderly.
7. Educate about dietary and lifestyle changes. (Decreasing alcohol intake, foods high
in purines, foods/drinks sweetened with fructose, weight reduction, and adequate
hydration)
Rationale: Doing so decreases the likelihood of future flare ups and/or attacks.
Rationale: Joint pain, particularly in the foot, will put them at higher risks for fall and
injury due to their impaired mobility.
Sources:
Singh, J. (2013) Racial and Gender Disparities in Patients with Gout retrieved
September 6, 2018 from
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545402/